Daily Wear Comparison of Enhanced and Non-Enhanced Silicone Hydrogel Lenses
This study has been completed.
Sponsor:
CIBA VISION
Information provided by (Responsible Party):
Alcon Research ( CIBA VISION )
ClinicalTrials.gov Identifier:
NCT00813982
First received: December 22, 2008
Last updated: June 26, 2012
Last verified: January 2011
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare an experimental contact lens with a currently marketed contact lens.
| Condition | Intervention |
|---|---|
|
Myopia |
Device: Lotrafilcon A Experimental Contact Lens Device: Lotrafilcon A Commercial Contact Lens |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Single Group Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Daily Wear Comparison of Enhanced and Non-Enhanced Silicone Hydrogel Lenses |
Resource links provided by NLM:
Further study details as provided by Alcon Research:
Primary Outcome Measures:
- Overall Vision [ Time Frame: 1 week ] [ Designated as safety issue: No ]Overall vision was interpreted by the subject and recorded on a questionnaire as a single, retrospective evaluation of 1-week wear time. Overall vision was evaluated by eye and rated on a 10-point scale, with 1 being poor and 10 being excellent.
| Enrollment: | 60 |
| Study Start Date: | November 2008 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Experimental Lotrafilcon A Contact Lens
Lotrafilcon A experimental contact lens randomly assigned to one eye
|
Device: Lotrafilcon A Experimental Contact Lens
Experimental spherical, silicone hydrogel soft contact lens
|
|
Active Comparator: Commercial Lotrafilcon A Contact Lens
Lotrafilcon A commercial contact lens randomly assigned to one eye
|
Device: Lotrafilcon A Commercial Contact Lens
Commercially marketed spherical, silicone hydrogel soft contact lens
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Able to wear contact lenses for a minimum of 5 days a week, at least 8 hours a day
- On exam have ocular findings that are considered normal and would not prevent the safe wear of contact lenses
- Other protocol-defined inclusion/exclusion criteria may apply
Exclusion Criteria:
- Requires concurrent ocular medication
- Eye injury or surgery within twelve weeks immediately prior to enrollment
- Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of their accessory solutions
- Any active corneal infection
- Any use of medications for which contact lens wear would be contraindicated
- History of corneal refractive surgery
- Wears toric contact lenses
- Other protocol-defined inclusion/exclusion criteria may apply
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Alcon Research ( CIBA VISION ) |
| ClinicalTrials.gov Identifier: | NCT00813982 History of Changes |
| Other Study ID Numbers: | P-335-C-009 |
| Study First Received: | December 22, 2008 |
| Results First Received: | September 3, 2010 |
| Last Updated: | June 26, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Myopia Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on May 21, 2013